O. Fouad

Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9–12 years) and adolescents

A. Allam, Ibrahim A. Elhenawy, M. Khedr, 2019, Hepatology International.

Interleukin 28B Polymorphism Predicted Treatment Response in Egyptian Children with Chronic Hepatitis C Virus Infection

M. Guindi, O. Fouad, Hala Said, 2021 .

Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years.

A. Marei, M. Sira, H. El-Araby, 2020, The Journal of pediatrics.